MKL - Markel Corporation Stock Analysis | Stock Taper
Logo
Markel Corporation

MKL

Markel Corporation NYSE
$1,815.59 -1.67% (-30.78)

Market Cap $22.72 B
52w High $2207.59
52w Low $1719.41
P/E 13.14
Volume 83.31K
Outstanding Shares 12.51M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q1-2026 $3.55B $2.66B $-212.29M -5.98% $-18.9 $-229.82M
Q4-2025 $4.22B $2.2B $576.81M 13.67% $48.95 $784.17M
Q3-2025 $4.39B $1.43B $751.34M 17.13% $59.44 $1.07B
Q2-2025 $4.41B $1.59B $657.15M 14.9% $49.8 $966.64M
Q1-2025 $3.33B $1.35B $121.71M 3.66% $12.11 $256.83M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q1-2026 $10.86B $68.6B $49.95B $18.13B
Q4-2025 $11.03B $68.91B $49.8B $18.6B
Q3-2025 $4.62B $50.7B $32.1B $18.04B
Q2-2025 $4.3B $49.44B $31.57B $17.32B
Q1-2025 $4.67B $48.65B $30.9B $17.15B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2026 $-204.36M $15.91M $-348.22M $-79.55M $-422.02M $-31.35M
Q4-2025 $576.81M $662.19M $-615.44M $-50.05M $-13.6M $599.07M
Q3-2025 $763.79M $1.22B $-719.3M $-170.83M $321.81M $1.17B
Q2-2025 $677.18M $504.4M $-109.41M $-821.95M $-379.85M $453.76M
Q1-2025 $129.35M $376.19M $192.81M $-105.8M $482.69M $335.48M

Revenue by Products

Product Q3-2024Q4-2024Q1-2025Q2-2025
Insurance
Insurance
$1.86Bn $1.86Bn $1.82Bn $0
Investing Member
Investing Member
$1.17Bn $370.00M $80.00M $0
Markel Ventures
Markel Ventures
$0 $0 $0 $1.55Bn
Markel Ventures Operations
Markel Ventures Operations
$1.26Bn $1.27Bn $1.13Bn $0
Reinsurance
Reinsurance
$250.00M $260.00M $270.00M $0

Q1 2026 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Markel Corporation's financial evolution and strategic trajectory over the past five years.

+ Strengths

Key strengths include a distinctive three‑engine business model, strong recovery and growth in profitability, and consistently robust free cash flow. The balance sheet has expanded with rising equity and retained earnings, while leverage remains moderate. Markel’s specialty focus, underwriting discipline, and long‑term investment orientation, combined with its portfolio of operating businesses, provide diversification that many traditional insurers lack. Its measured embrace of technology and insurtech partnerships further supports underwriting quality and operational efficiency.

! Risks

Main risks center on the inherent volatility of insurance and investment results, as seen in past loss years and revenue swings. The recent revenue contraction after a period of strong growth raises questions about market conditions and competitive dynamics. Catastrophe events, liability inflation, regulatory changes, and pricing cycles can all pressure underwriting profitability. On the financial side, the shift from net cash to net debt, increased shareholder distributions, and opacity around some liquidity metrics modestly raise financial risk, while acquisitions within Markel Ventures carry integration and execution risk.

Outlook

Overall, the data depict a company that has emerged from a difficult period with stronger profitability, a larger capital base, and multiple engines of cash generation. Its long‑term prospects depend on maintaining underwriting discipline, navigating insurance cycles, compounding investment returns prudently, and continuing to build Markel Ventures without sacrificing quality. Results are likely to remain lumpy year to year due to the nature of the business, but the structural setup and recent trends suggest it is well placed to continue pursuing long‑term value creation if current strategies are sustained and risks are managed carefully.